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ABSTRACT
An experimental data handling system has been
created as an update to the previous Nucleolar
Proteome Database (NOPdb3.0: http://www.lamon
dlab.com/NOPdb3.0/). This updated system is able
to manage large data sets identified by multiple
mass spectrometry and has been used to analyse
highly purified preparations of human nucleoli from
different cell lines. The newly created application
includes a dynamic relational database, which is
kept up to date by laboratory staff. The data are
further annotated with information from specific
external sources on the web, including the IPI and
Gene Ontology databases. In addition, an Applica-
tion Programming Interface provides external users
with a portal to link into the nucleolar proteome
database and hence, gain access to continually
updated results. From the initial ~700 human pro-
teins identified in the previous iteration of the
NOPdb, we have now identified over 50000 peptides
contained in over 4500 human proteins from purified
nucleoli, providing enhanced coverage of the
nucleolar proteome.
INTRODUCTION
The nucleolus is a highly conserved nuclear organelle
whose main function is to coordinate the synthesis and
assembly of ribosome subunits (1). Previously we described
a Nucleolar Proteome Database (NOPdb2.0: http://www.
lamondlab.com/NOPdb) that archived data on >700 pro-
teins that were identiﬁed by multiple mass spectrometry
(MS) analyses from highly puriﬁed preparations of
human nucleoli (2). Each protein entry was annotated
with information about its corresponding gene, its domain
structures and relevant protein homologues across species,
as well as documenting its MS identiﬁcation history,
including all the peptides sequenced by tandem MS/MS.
Moreover, data showing the quantitative changes in the
relative levels of approximately 500 nucleolar proteins
werecomparedatdiﬀerenttimepointsupontranscriptional
inhibition (3).
The data presented by the previous NOPdb, version 2.0,
was held in a ﬂat ﬁle database. Due to the aggregated
nature of the data, results from individual experiments
could not be extracted. The peptide data for a single pro-
tein were merged within this database rather than stored
separately. The client interface to this database consisted
of Perl CGI scripts. These scripts were able to extract the
relevant data from the ﬂat ﬁle database to create static
html pages. After running the scripts, a page was created
on the server for each protein. The html pages were then
made available to the global community via the internet.
Each time data were updated in the ﬂat ﬁles, the Perl
scripts had to be run again in order to reproduce the
static html pages. This process of having to reproduce
the static html protein pages after each database update
was highly ineﬃcient and time consuming. A more eﬃ-
cient approach is to produce dynamic html pages upon
user request. Furthermore, the capabilities of the version
2.0 NOPdb database were limited with respect to security,
ease of use, accessibility, maintainability and expandabil-
ity. For example, a number of security concerns arose
regarding the Perl scripts, which with limited documenta-
tion, proved very diﬃcult to resolve.
The new version of the NOPdb3.0 (http://www.lamon
dlab.com/NOPdb3.0/) consists of a unique, secure, extend-
able content management system, holding advanced
nucleolar proteomics data. The created application
includes a dynamic relational database, which is kept up
todatebymembersoftheLamondgroup.Italsoallowsthe
query of protein data hosted within the database by exter-
nal users, either using the custom built interface provided
by the Lamond group, or by building custom web tools
that access data via the Application Programming
Interface (API). In addition to the dynamic interfaces pro-
vided by the new content management system, the data
included in the nucleolar proteome are also dynamically
updated with proteins identiﬁed from several diﬀerent
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laboratory. From the initial 700 proteins identiﬁed in
the previous iteration of the NOPdb, we have now identi-
ﬁed over 50000 peptides contained in over 4500 human
proteins from puriﬁed nucleoli, providing signiﬁcantly
enhanced coverage of the nucleolar proteome.
DATABASE ACCESS
We have established the new version of the Nucleolar
Proteome Database (NOPdb3.0), which archives all the
human nucleolar proteins identiﬁed to date by the
Lamond group and their collaborators using MS analyses
(1–3). This current version 3.0 of the database is avail-
able at http://www.lamondlab.com/NOPdb3.0/ and is
searchable either by protein name, protein sequence,
motif (4–6), Gene Ontology (GO) (7) terms or by setting
the range of the predicted isoelectric point and/or mole-
cular weight (Figure 1). To date, NOPdb3.0 archives over
4500 human nucleolar proteins veriﬁed by multiple MS
analyses in diﬀerent cell lines. The NOPdb3.0 provides
information on multiple parameters, including protein
name, accession number, gene symbol, gene name,
sequence, molecular weight, isoelectric point (pI), peptides
identiﬁed, experiments in which the protein was identiﬁed,
motifs and GO annotation. The previous version of the
database (2) will still be available through our website at
http://www.lamondlab.com/NOPdb/.
DATABASE IMPLEMENTATION
The new NOPdb3.0 application consists of a multi-tier
architecture, where the data storage, business logic and
client interface are separate components. The data storage
is implemented via a relational mySQL database. The
database is structured (Figure 2) to allow easy extendibility
and maintenance in the future. In order to extract useful
data, the business logic employs complex SQL queries. The
purpose of the business logic layer is to act as an interface
between the client-side application and database. The busi-
ness logic and client interface can both reside on any
Apache web server capable of serving PHP classes and
the client interface, which is built in Adobe Flex. Adobe
Flex was chosen as it allows Rich Internet Applications
(RIAs) to be prototyped and developed rapidly, with
the end product running across a wide range of client
browsers.
Figure 1. Snapshots of the NOPdb3.0 (http://www.lamondlab.com/NOPdb3.0/). For illustration, the database was searched to identify a Protein
Phosphatase 1 (PP1) isoform and here we show an overview page for this protein documenting its sequence, peptides identiﬁed, etc.
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tation using a fully relational design with major improve-
ments over previous versions and additional functionality.
The newly created database holds data of higher granu-
larity, storing data at the peptide level as opposed to
collated data on proteins. This higher granularity also
means that results from new experiments can be directly
uploaded to the database without prior processing, as the
direct output from MS-based proteomics analyses is pep-
tide data. The application has the ability to interpret data
and therefore aggregate it to provide metadata for pro-
teins on a usable, graphical interface. The structure of the
application has been designed using the model view con-
troller design pattern (8), thus meaning that the function-
ality is separated from the overall look and feel of the
application to ensure a more customisable solution. All
communication between the database and application
has been implemented to pass through the custom made
API (9). Furthermore, in this new version 3.0 application,
the graphical user interface to the database is able to create
data pages ‘on the ﬂy’ using the custom API rather than
serving static data pages, as in previous versions. This
API not only acts as a security blanket around the data-
base, it also provides the ability for users to create their
own websites and/or applications that represent the data
being stored in the proteomics database. External users
can make use of the API through the REST (Representa-
tional State Transfer) (10) approach. Hence, external
programmers can retrieve content in XML (Extensible
Markup Language) format, from the database, by access-
ing well-documented Uniform Resource Locators
(URLs).
The application also facilitates mining of stored data,
with data being stored in a relational structure that is
well documented. Thus tools can be built to search, ana-
lyse, read and understand the data. This mining capability
is evident within the application, with the database being
searchable by multiple parameters, including gene names,
amino acid or nucleotide sequences, sequence motifs, or
by limiting the range for isoelectric points and/or molecu-
lar weights. The database is also searchable by Interpro
motif numbers (database of protein families, domains
and functional sites) (4–6) and by GO terms (describe
gene products in terms of their associated biological pro-
cesses, cellular components and molecular functions in
a species-independent manner) (7). Furthermore, the
NOPdb3.0 application uses the API to create dynamically
generated graphs, allowing the users to visualise the data
produced from experiments and enabling cross analysis
between experiments.
Increased security was a core focus of this development.
The application itself is designed with three levels of
access, to facilitate management and to prevent unautho-
rised use of the system. Users are provided with diﬀerent
levels of access according to their needs, which are seam-
lessly enforced by the application. This security ensures
Figure 2. Entity Relationship (ER) diagram depicting the relationships between the tables present in the mySQL database implemented for the
NOPdb3.0 Content Management System.
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not compromised. Furthermore, this application creates a
platform for the Lamond group to share their data with
the wider cell biology community.
DATABASE CONTENT
The database has been populated with diﬀerent sets of
experiments, performed in the Lamond laboratory, that
identify proteins in puriﬁed preparations of human
nucleoli. This new NOPdb3.0 now contains over 4500
proteins identiﬁed in diﬀerent human cells lines. The
increased coverage of the human nucleolus proteome is
illustrated by the fact that NOPdb3.0 now includes over
80% of ribosomal proteins, as opposed to the 28%
described in NOPdb version 2.0. We estimate that
NOPdb3.0 contains over 80% of the main human nucleo-
lus proteins. The proteins in the database will be regularly
updated as more experiments are performed in the
Lamond laboratory.
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